ICAM1 and cutaneous mastocytosis: Paradoxically, individuals with one such polymorphism, ICAM-1Kilifi, which results in the production of an endothelial ICAM-1 molecule with lower affinity to iRBC binding, have an increased risk of developing CM (Fernandez-Reyes et al, 1997).